Article
Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis.
Rheumatology (Oxford, England) - 1 Jan 2010
Hassan Batool, Maxwell James R, Hyrich Kimme L, Barton Anne, Worthington Jane, Isaacs John D, Morgan Ann W, Wilson Anthony G
Abstract excerpt
OBJECTIVES: To investigate the association between genotype at the soluble interleukin 6 receptor (sIL-6R) A358C single nucleotide polymorphism (SNP, rs8192284), previously reported to correlate with soluble receptor levels, and response to anti-TNF therapy in subjects with RA. METHODS: In a larg...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
